Literature DB >> 23105250

Serum levels of bone alkaline phosphatase in breast and prostate cancers with bone metastasis.

G Ramaswamy1, V R Rao, L Krishnamoorthy, G Ramesh, R Gomathy, D Renukadevi.   

Abstract

BALP activity in the sera of metastatic patients of breast and prostate malignancy has increased significantly. Our studies with patients in India conform the earlier reports that BALP may have a useful complementary role in the early diagnosis of bone metastases.

Entities:  

Keywords:  BALP activity; breast cancer; prostate cancer

Year:  2000        PMID： 23105250      PMCID： PMC3453965          DOI： 10.1007/BF02883737

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN： 0970-1915


  17 in total

1.  Bone-alkaline phosphatase as indicator of bone formation.

Authors:  J P van Straalen; E Sanders; M F Prummel; G T Sanders
Journal:  Clin Chim Acta       Date:  1991-09-14       Impact factor: 3.786

Review 2.  Alkaline phosphatase isozymes: recent progress.

Authors:  W H Fishman
Journal:  Clin Biochem       Date:  1990-04       Impact factor: 3.281

3.  Differential patterns of bone turnover in relation to bone pain and disease extent in bone in cancer patients with skeletal metastases.

Authors:  A Berruti; L Dogliotti; G Gorzegno; M Torta; M Tampellini; M Tucci; S Cerutti; M M Frezet; M Stivanello; G Sacchetto; A Angeli
Journal:  Clin Chem       Date:  1999-08       Impact factor: 8.327

4.  Human osteosarcoma cells spontaneously release matrix-vesicle-like structures with the capacity to mineralize.

Authors:  K N Fedde
Journal:  Bone Miner       Date:  1992-05

5.  Skeletal alkaline phosphatase activity as a bone formation index in vitro.

Authors:  J R Farley; D J Baylink
Journal:  Metabolism       Date:  1986-06       Impact factor: 8.694

6.  Metastatic workup of patients with prostate cancer employing alkaline phosphatase and skeletal alkaline phosphatase.

Authors:  J M Wolff; T H Ittel; H Borchers; O Boekels; G Jakse
Journal:  Anticancer Res       Date:  1999 Jul-Aug       Impact factor: 2.480

7.  Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease.

Authors:  P Garnero; P D Delmas
Journal:  J Clin Endocrinol Metab       Date:  1993-10       Impact factor: 5.958

8.  Alkaline phosphatase isoenzyme patterns in malignant disease.

Authors:  V O Van Hoof; A T Van Oosterom; L G Lepoutre; M E De Broe
Journal:  Clin Chem       Date:  1992-12       Impact factor: 8.327

9.  Method for determination of bone alkaline phosphatase activity: analytical performance and clinical usefulness in patients with metabolic and malignant bone diseases.

Authors:  W Withold; U Schulte; H Reinauer
Journal:  Clin Chem       Date:  1996-02       Impact factor: 8.327

10.  Quantification of bone alkaline phosphatase in serum by precipitation with wheat-germ lectin: a simplified method and its clinical plausibility.

Authors:  W Behr; J Barnert
Journal:  Clin Chem       Date:  1986-10       Impact factor: 8.327
View more
  10 in total

1.  Spectrophotometric determination of the activity of alkaline phosphatase and detection of its inhibitors by exploiting the pyrophosphate-accelerated oxidase-like activity of nanoceria.

Authors:  Pengjuan Ni; Junfeng Xie; Chuanxia Chen; Yuanyuan Jiang; Zhenlu Zhao; Yan Zhang; Yizhong Lu; Jinghua Yu
Journal:  Mikrochim Acta       Date:  2019-05-02       Impact factor: 5.833

2.  Ultrafine Angelica gigas powder normalizes ovarian hormone levels and has antiosteoporosis properties in ovariectomized rats: particle size effect.

Authors:  Kyeong-Ok Choi; Inae Lee; Sae-Yeol-Rim Paik; Dong Eun Kim; Jung Dae Lim; Wie-Soo Kang; Sanghoon Ko
Journal:  J Med Food       Date:  2012-10       Impact factor: 2.786

3.  Three gold indicators for breast cancer prognosis: a case-control study with ROC analysis for novel ratios related to CBC with (ALP and LDH).

Authors:  Noha Mohamed Said
Journal:  Mol Biol Rep       Date:  2019-01-31       Impact factor: 2.316

4.  Studies of biochemical parameters in breast cancer with and without metastasis.

Authors:  Sandhya Mishra; D C Sharma; Praveen Sharma
Journal:  Indian J Clin Biochem       Date:  2004-01

5.  Fluorometric determination of the activity of alkaline phosphatase based on the competitive binding of gold nanoparticles and pyrophosphate to CePO4:Tb nanorods.

Authors:  Ai-Zhen Xu; Li Zhang; Hui-Hui Zeng; Ru-Ping Liang; Jian-Ding Qiu
Journal:  Mikrochim Acta       Date:  2018-05-09       Impact factor: 5.833

6.  Advanced stage of breast cancer hoist alkaline phosphatase activity: risk factor for females in India.

Authors:  A K Singh; A Pandey; M Tewari; R Kumar; A Sharma; K A Singh; H P Pandey; H S Shukla
Journal:  3 Biotech       Date:  2013-01-06       Impact factor: 2.406

7.  Pre-treatment serum alkaline phosphatase and lactate dehydrogenase as prognostic factors in triple negative breast cancer.

Authors:  Bo Chen; Danian Dai; Hailin Tang; Xi Chen; Xiaohong Ai; Xiaojia Huang; Weidong Wei; Xiaoming Xie
Journal:  J Cancer       Date:  2016-11-25       Impact factor: 4.207

8.  Signal transduction and amplification through enzyme-triggered ligand release and accelerated catalysis.

Authors:  Sean Goggins; Barrie J Marsh; Anneke T Lubben; Christopher G Frost
Journal:  Chem Sci       Date:  2015-06-15       Impact factor: 9.825

9.  Combined analysis and validation for DNA methylation and gene expression profiles associated with prostate cancer.

Authors:  Yanqiu Tong; Yang Song; Shixiong Deng
Journal:  Cancer Cell Int       Date:  2019-03-04       Impact factor: 5.722

10.  High uric acid (UA) downregulates bone alkaline phosphatase (BALP) expression through inhibition of its promoter activity.

Authors:  Zhi-Qi Wu; Xiao-Ting Chen; Yan-Yan Xu; Ming-Jie Tian; Hai-Yan Chen; Guo-Ping Zhou; Hua-Guo Xu
Journal:  Oncotarget       Date:  2017-09-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.